Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 1;33(3):453.
doi: 10.1097/MEG.0000000000001945.

Adalimumab-induced leukocytoclastic vasculitis in a Crohn's disease patient

Affiliations

Adalimumab-induced leukocytoclastic vasculitis in a Crohn's disease patient

Guilherme G L Cançado et al. Eur J Gastroenterol Hepatol. .
No abstract available

PubMed Disclaimer

References

    1. Sokumbi O, Wetter DA, Makol A, Warrington KJ. Vasculitis associated with tumor necrosis factor-α inhibitors. Mayo Clin Proc. 2012; 87:739–745.
    1. Bernardes C, Carvalho D, Saiote J, Ramos J. Leukocytoclastic vasculitis complicating adalimumab therapy for Crohn’s disease: report of three cases. Gastroenterol Hepatol. 2018; 41:442–443.
    1. Villafranca CM, Belloso RMI, Rodriguez MTB, Olabarrieta SB. Vasculitis por adalimumab en un paciente con enfermedad de Crohn. Gastroenterol Hepatol. 2013; 36:296–297. https://linkinghub.elsevier.com/retrieve/pii/S0210570512003135 . [Accessed 21 August 2020]
    1. Cury DB, de Souza AW, Vianna GA, Odashiro D, Farias A, Moss AC. Cutaneous vasculitis in a patient with crohn’s disease treated with adalimumab. Inflamm Bowel Dis. 2017; 23:E1–E2.
    1. Shivaji UN, Awasthi AK, Aherne R. Cutaneous vasculitis caused by anti-tumor necrosis factor therapy: a case report. Clin Gastroenterol Hepatol. 2016; 14:e1–e2.

MeSH terms

Supplementary concepts

LinkOut - more resources